U.S. Healthcare Leaders Expect Widespread Adoption of AI By 2023

Today, Intel Corporation revealed the findings from a new study conducted in partnership with Convergys Analytics that surveyed 200 U.S. healthcare decision-makers in April 2018 on their attitudes about artificial intelligence (AI) and perceived barriers to adoption in the industry. AI today is already being applied behind the scenes to detect drug interactions and predict which patients are most at risk for readmissions or experiencing a hospital-acquired condition. We know the promise of AI is much greater: It has the potential to improve clinical effectiveness, reduce cost and increase the quality of patient care.